Latest Race Oncology News

+

Race Oncology CEO Phillip Lynch and CSO Dr Daniel Tillett present Race's June 2022 Quarterly Investor Briefing followed by a…

June-2022-Quarterly-Activity-ReportDownload

30 June 2022 – Race Oncology Limited (“Race”) is pleased to share further interim results from our preclinical cardioprotection program…